Assenagon Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,413
| Closed | -$164K | – | 1289 |
|
|
2024
Q3 | $164K | Sell |
23,413
-594,497
| -96% | -$4.17M | ﹤0.01% | 1296 |
|
|
2024
Q2 | $4.24M | Buy |
617,910
+259,191
| +72% | +$1.78M | 0.01% | 658 |
|
|
2024
Q1 | $5.07M | Buy |
+358,719
| New | +$5.07M | 0.01% | 582 |
|
|
2023
Q2 | – | Sell |
-840,651
| Closed | -$603K | – | 1275 |
|
|
2023
Q1 | $603K | Hold |
840,651
| – | – | ﹤0.01% | 1139 |
|
|
2022
Q4 | $487K | Sell |
840,651
-101,100
| -11% | -$58.6K | ﹤0.01% | 1127 |
|
|
2022
Q3 | $895K | Hold |
941,751
| – | – | ﹤0.01% | 930 |
|
|
2022
Q2 | $1.13M | Sell |
941,751
-50,978
| -5% | -$61.2K | ﹤0.01% | 1012 |
|
|
2022
Q1 | $1.3M | Buy |
992,729
+553,155
| +126% | +$724K | ﹤0.01% | 954 |
|
|
2021
Q4 | $774K | Sell |
439,574
-1,027,233
| -70% | -$1.81M | ﹤0.01% | 1063 |
|
|
2021
Q3 | $3.18M | Sell |
1,466,807
-159,891
| -10% | -$347K | 0.01% | 520 |
|
|
2021
Q2 | $5.69M | Buy |
+1,626,698
| New | +$5.69M | 0.02% | 426 |
|
|
2021
Q1 | – | Sell |
-22,198
| Closed | -$241K | – | 1142 |
|
|
2020
Q4 | $241K | Sell |
22,198
-251,003
| -92% | -$2.73M | ﹤0.01% | 895 |
|
|
2020
Q3 | $2.81M | Sell |
273,201
-47,014
| -15% | -$484K | 0.02% | 466 |
|
|
2020
Q2 | $6.69M | Buy |
+320,215
| New | +$6.69M | 0.04% | 244 |
|
|
2019
Q1 | – | Sell |
-100,558
| Closed | -$317K | – | 883 |
|
|
2018
Q4 | $317K | Buy |
+100,558
| New | +$317K | ﹤0.01% | 869 |
|